<DOC>
	<DOCNO>NCT00915239</DOCNO>
	<brief_summary>The purpose study determine whether proton pump inhibitor ( PPI ) induce hypersecretion lead acid relate symptom treatment healthy volunteer .</brief_summary>
	<brief_title>Symptom Evaluation After Cessation Proton Pump Inhibitor Healthy Volunteers</brief_title>
	<detailed_description>Treatment proton pump inhibitor ( PPI ) show cause rebound hypersecretion gastric acid . The clinical significance phenomenon however unclear . This study aim examine whether healthy volunteer , relatively short period time treat PPI , develop dyspeptic symptom cessation therapy . Dyspeptic symptom measure subjectively use validate questionnaire , fill day . Gastric acid measure indirectly measurement acid secretion marker ( Gastrin chromogranin-A ) .</detailed_description>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Healthy volunteer 1870 year age Informed consent No prior history GI disorder Dyspeptic complaint H. pylori infection Ongoing treatment painrelieving medication ( i.e. , NSAID ) Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>volunteer</keyword>
</DOC>